ATC Group: D07XC Corticosteroids, potent, other combinations

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D07XC in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D07 Corticosteroids, dermatological preparations
3 D07X Corticosteroids, other combinations
4 D07XC Corticosteroids, potent, other combinations

Group D07XC contents

Code Title
D07XC01 Betamethasone
D07XC02 Desoximetasone
D07XC03 Mometasone
D07XC04 Diflucortolone
D07XC05

Active ingredients in D07XC

Active Ingredient Description
Betamethasone

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.

Desoximetasone

Desoximetasone is a synthetic corticosteroid. Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. Desoximetasone is used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Diflucortolone

Diflucortolone is a topically acting fluoridated corticosteroid which suppresses inflammation in inflammatory and allergic skin conditions and alleviates the subjective complaints such as itching, burning and pain.

Fluocortolone

Fluocortolone pivalate inhibits inflammatory and allergic skin reactions, and alleviates subjective complaints such as pruritus, smarting, and pain. The substance reduces dilatation of the capillaries, oedema of the interstitial cells and infiltration of the tissues. Capillary multiplication is inhibited.

Mometasone

Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade.

Related product monographs

Title Information Source Document Type  
DIPROSALIC Ointment Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC